Member Info for Ctw2014

Good news I thought. Surprised no comment. Oh well, steady as she goes.

That’s because a lot of the trades are buys irrespective of colour, including mine!

Agreed. Two very solid RNSs following up a long series of positive news.

Let’s hope we go blue this time. Surely the market will see this as a significant development and not Covid dependent.

At the end of the day, the issues at Southwark don’t affect first gas, and that is what the short term market will care about.

I must admit, I thought that about Cora but then had it pointed out to me (not for the first time) that they are not yet producing, and I think the same is true of Endeavour in Mali. Sanctions will obviously not be such an issue for them. Having said that, I am not convinced that the sanctions will be a big deal for Hum either.

Just my opinion of course, not advice.

It will. Trading update was 9th Feb last year.

Happy New Year all holders. Has been building slowly and steadily and now looks good for 2022 in my view. Please DYOR.

Should be showing as top of the Risers board but typically nowhere to be seen!

What a stunning RNS and clearly plenty more to come. T42 is going to be a beast compared to the old STAR. Well done LTRs

The volume may be low but a lot of the buys have been in round number chunks for a while now, which suggests to me someone is accumulating. My guess is Meditech trying to quietly acquire its minimum two and a half % while the sp is below 35p.

Silly BOT trades of a few quid at wonky prices distort the market and make it more difficult for ordinary investors/traders for sure. Bloody nuisance.

Best wishes Gerry, and please keep up the good work in 2022!

Obviously

It’s an award under a framework contract. The value on bidstats is I assume the potential value under the whole framework contract. This is one award to YGEN. There will have been and will be other awards. Value to YGEN will depend on take up as explained but it’s good news obvioutlying.

Very good terms in my view.

And TRAC doesn’t show on the risers/fallers lists when they should.

Nice to get some decent results out for Xmas. Let’s hope the market reacts accordingly.

What has been delivered with that RNS is great, but for me, what is more exciting, is what is flagged up as potential over the coming months. 2022 could be a fantastic, transformative year for TRAC. GLA and well done all LTHs for sticking with it through the lean times.